Studies on heterologous anti-lymphocyte serum in mice. I. In vitro and in vivo properties.

PubWeight™: 5.59‹?› | Rank: Top 1%

🔗 View Article (PMID 4956647)

Published in J Immunol on February 01, 1966

Authors

J G Gray, A P Monaco, M L Wood, P S Russell

Articles citing this

Nature and mode of action of antilymphocytic antiserum. Proc Natl Acad Sci U S A (1966) 7.56

The use of heterologous antilymphoid agents in canine renal and liver homotransplantation and in human renal homotransplantation. Surg Gynecol Obstet (1967) 7.24

The preparation and testing of horse antidog and antihuman antilymphoid plasma or serum and its protein fractions. Surg Gynecol Obstet (1967) 3.86

Anti-lymphocytic antibody--a review. Clin Exp Immunol (1967) 2.75

Clinical reactions and serologic changes after the administration of heterologous antilymphocyte globulin to human recipients of renal homografts. Ann Intern Med (1968) 2.72

Suppression of adjuvant disease in the rat by heterologous antilymphocyte globulin. J Exp Med (1968) 2.27

An analysis of the effects of some types of anti-lymphocyte sera on contact hypersensitivity and certain models of inflammation. Immunology (1968) 2.07

Avenues of future research in homotransplantation of the liver with particular reference to hepatic supportive procedures, antilymphocyte serum, and tissue typing. Am J Surg (1966) 1.89

Ex vivo preservation and expansion of human limbal epithelial stem cells on amniotic membrane cultures. Br J Ophthalmol (2002) 1.77

The selective action of antilymphocyte serum on recirculating lymphocytes: a review of the evidence and alternatives. Clin Exp Immunol (1970) 1.76

Regulation of the immune system by synthetic polynucleotides. 3. Action on antigen-reactive cells of thymic origin. J Exp Med (1971) 1.63

Histopathological effects in mice of heterologous antilymphocyte serum. J Exp Med (1968) 1.61

The inhibition of granuloma formation around Schistosoma mansoni eggs. 3. Heterologous antilymphocyte serum. Am J Pathol (1968) 1.58

Renal transplantation in the inbred rat. 3. A study of heterologous anti-thymocyte sera. J Exp Med (1967) 1.57

Anti-lymphocytic antibody and autoimmune disease: a review. Clin Exp Immunol (1969) 1.53

Effects of heterologous anti-lymphocyte serum on the distribution of 51-Cr-labelled lymph node cells in mice. Immunology (1968) 1.52

Effect of antilymphocyte serum on animals experimentally infected with Histoplasma capsulatum or Cryptococcus neoformans. J Bacteriol (1969) 1.48

A quantitative study of the stimulation of DNA synthesis in lymph node cell cultures by anti-lymphocyte serum, anti-gamma globulin serum, specific antigen, and phytohemagglutinin. J Exp Med (1969) 1.47

The provocation of latent lymphocytic choriomeningitis virus infections in mice by treatment with antilymphocytic serum. J Exp Med (1968) 1.46

Response to phytohaemagglutinin of lymphocytes from mice treated with anti-lymphocyte globulin. Immunology (1969) 1.41

Further evidence concerning the autoantigenic status of the trophoblast. J Exp Med (1972) 1.34

Studies on red cell aplasia. I. Demonstration of a plasma inhibitor to heme synthesis and an antibody to erythroblast nuclei. Proc Natl Acad Sci U S A (1967) 1.24

Lymphocytosis and histamine sensitization of mice by fractions from Bordetella pertussis. J Bacteriol (1968) 1.22

On the mode of action of antilymphocytic serum: experiments on electrophoretic mobility of macrophages in experimental allergic encephalomyelitis. Clin Exp Immunol (1970) 1.15

The effect of heterologous anti-lymphocyte seerum on mouse hemopoietic stem cells. J Exp Med (1968) 1.07

Effects of antimacrophage, antithymocyte, antilymphocyte and antispleen serum on the immune response in mice. Clin Exp Immunol (1970) 1.05

Flare-up of antigen-induced arthritis in mice after challenge with intravenous antigen: effects of pre-treatment with cobra venom factor and anti-lymphocyte serum. Clin Exp Immunol (1984) 1.05

The effect of heterologous anti-lymphocytic serum on the small lymphocyte population of rats. J Exp Med (1968) 1.01

Mechanism of induction of immunological tolerance. VI. Tolerance induction following thoracic duct drainage or treatment with anti-lymphocyte serum. Immunology (1969) 1.01

The effect of anti-lymphocyte globulin on human monocytes in vitro. Clin Exp Immunol (1969) 0.98

Interspecies reactivity and intraspecies specificity of antilymphoid globulin. Surgery (1967) 0.97

Studies on antilymphocyte antibody in the chicken. I. Effect of rabbit antithymus and antibursa globulin on chicken embryos. Clin Exp Immunol (1970) 0.95

Prolonged administration of antithymocyte serum in mice. II. Histopathological investigation. Clin Exp Immunol (1971) 0.94

An analysis of graft-versus-host disease in Syrian hamsters. II. The epidermolytic syndrome: studies on its pathogenesis. J Exp Med (1970) 0.93

Use of anti-lymphocyte serum to prolong dog homograft survival. Surg Forum (1966) 0.89

Leucoagglutination and cytotoxicity of the serum of infected mice and of extracts of Trichinella spiralis larvae and the capacity of infected mouse sera to prolong skin allografts. Immunology (1975) 0.88

Modification of the graft-versus-host syndrome by anti-lymphocyte serum treatment of the donor. Clin Exp Immunol (1968) 0.87

Modification of the graft-versus-host syndrome by anti-lymphocyte serum treatment of the host. Clin Exp Immunol (1968) 0.86

Combined immunosuppression for canine renal allograft prolongation: antilymphocyte serum plus prednisolone or azathioprine. Ann Surg (1968) 0.86

Effect of antilymphocyte serum on macrophage activity. Clin Exp Immunol (1970) 0.85

The lymphatic status of hamster cheek pouch tissue in relation to its properties as a graft and as a graft site. J Exp Med (1971) 0.85

Cytology and histology of haemopoietic cell transplantation under the influence of antilymphocyte serum (ALS) in mice. I. The in vivo effect of antilymphocytic globulin on haemopoietic tissue. Clin Exp Immunol (1971) 0.84

Immunopathology of New Zealand Black mice treated with antilymphocyte globulin. Immunology (1971) 0.84

Immunosuppressive and graft-rejecting anti--bodies in heterologous anti-lymphocytic serum. J Exp Med (1971) 0.83

Stress effect of antilymphocyte serum. Br Med J (1969) 0.83

Prolongation of canine renal allografts by horse anti-dog lymphocyte serum and globulin. Ann Surg (1969) 0.81

Patterns of vascular damage in the antibody-mediated rejection of skin xenografts in the mouse. Am J Pathol (1980) 0.81

Further studies on the biological properties of guinea-pig IgG1 antibodies: anti-lymphocyte antibodies. Immunology (1974) 0.80

Kinetics and immunoglobulin nature of the antibody response to Mycobacterium tuberculosis. J Bacteriol (1967) 0.79

The suppression of rejection of Nippostrongylus brasiliensis in the rat by promethazine hydrochloride. The site of immunological impairment. Immunology (1972) 0.78

Experience with transplantation of the kidney in man. Ann R Coll Surg Engl (1966) 0.76

Effect of thymectomy and antilymphocyte serum on Mycobacterium leprae infection in mice. Infect Immun (1975) 0.75

The effect of sheep antilymphocyte plasma on the survival of dog renal allografts. Proc R Soc Med (1968) 0.75

Antilymphocyte serum. Br Med J (1967) 0.75

Antilymphocyte serum and glomerulonephritis. Br Med J (1970) 0.75

Regulation of anti-hapten antibody response by chemically modified carrier antigen preferentially provoking delayed-type hypersensitivity. I. Possible T-T cell interaction in the suppression of antibody response. Immunology (1977) 0.75

A technique for detection of agglutinating activity of antilymphocytic serum using formalinized and trypan-blue-stained lymphocytes. Clin Exp Immunol (1970) 0.75

Effects of antilymphocyte serum in neonatally thymectomized mice. Am J Pathol (1971) 0.75

Experimental glomerulonephritis in the mouse. II. Effect of antithymocyte globulin. Clin Exp Immunol (1972) 0.75

Amyloidosis in neonatally thymectomized and anti-lymphocyte serum treated mice. Clin Exp Immunol (1969) 0.75

Articles by these authors

Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell (1987) 16.01

The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein. Cell (1988) 10.75

A forkhead-domain gene is mutated in a severe speech and language disorder. Nature (2001) 9.25

Isolation of candidate cDNAs for portions of the Duchenne muscular dystrophy gene. Nature (1986) 6.45

Cloning the gene for an inherited human disorder--chronic granulomatous disease--on the basis of its chromosomal location. Nature (1986) 6.34

Primarily vascularized allografts of hearts in mice. The role of H-2D, H-2K, and non-H-2 antigens in rejection. Transplantation (1973) 6.01

Specific cloning of DNA fragments absent from the DNA of a male patient with an X chromosome deletion. Proc Natl Acad Sci U S A (1985) 5.50

Transplantation of small bowel in the rat: technical and immunological considerations. Surgery (1971) 5.05

Detection of deletions spanning the Duchenne muscular dystrophy locus using a tightly linked DNA segment. Nature (1985) 4.62

Studies on heterologous anti-lymphocyte serum in mice. II. Effect on the immune response. J Immunol (1966) 4.49

Analysis of deletions in DNA from patients with Becker and Duchenne muscular dystrophy. Nature (1986) 4.13

Isolation of a candidate gene for Menkes disease that encodes a potential heavy metal binding protein. Nat Genet (1993) 3.63

Use of monoclonal antibodies to T-cell subsets for immunologic monitoring and treatment in recipients of renal allografts. N Engl J Med (1981) 3.63

An improved method for isolation of mouse pancreatic islets. Transplantation (1985) 3.52

LRRTM1 on chromosome 2p12 is a maternally suppressed gene that is associated paternally with handedness and schizophrenia. Mol Psychiatry (2007) 3.49

A survey of nasotracheal intubating skills among Advanced Trauma Life Support course graduates. Br J Anaesth (1994) 3.29

Mutations in ATP2A2, encoding a Ca2+ pump, cause Darier disease. Nat Genet (1999) 3.25

Charcot-Marie-Tooth type 4B is caused by mutations in the gene encoding myotubularin-related protein-2. Nat Genet (2000) 2.96

The UTX gene escapes X inactivation in mice and humans. Hum Mol Genet (1998) 2.91

Yeast artificial chromosome libraries containing large inserts from mouse and human DNA. Proc Natl Acad Sci U S A (1991) 2.89

Localization and cloning of Xp21 deletion breakpoints involved in muscular dystrophy. Hum Genet (1987) 2.64

Adult Thymectomy: Effect on Recovery from Immunologic Depression in Mice. Science (1965) 2.41

Guidelines for the management of alopecia areata. Br J Dermatol (2003) 2.41

A quantitative-trait locus on chromosome 6p influences different aspects of developmental dyslexia. Am J Hum Genet (1999) 2.38

Association between X-linked mixed deafness and mutations in the POU domain gene POU3F4. Science (1995) 2.38

Widespread and selective induction of major histocompatibility complex-determined antigens in vivo by gamma interferon. J Exp Med (1985) 2.34

Localisation of a gene implicated in a severe speech and language disorder. Nat Genet (1998) 2.33

Treatment of acute renal allograft rejection with OKT3 monoclonal antibody. Transplantation (1981) 2.22

Influence of rejection therapy on fungal and nocardial infections in renal-transplant recipients. Lancet (1973) 2.22

Construction, arraying, and high-density screening of large insert libraries of human chromosomes X and 21: their potential use as reference libraries. Proc Natl Acad Sci U S A (1991) 2.21

The immunologic response to xenografts. Recognition of mouse H-2 histocompatibility antigens by the rat. J Immunol (1971) 2.17

A novel pathway of chronic allograft rejection mediated by NK cells and alloantibody. Am J Transplant (2011) 2.16

Use of gene fusions and protein-protein interaction in the isolation of a biologically active regulatory protein: the replication initiator protein of plasmid R6K. Proc Natl Acad Sci U S A (1983) 2.14

Reproducible high yield of rat islets by stationary in vitro digestion following pancreatic ductal or portal venous collagenase injection. Transplantation (1987) 2.14

A physical map of 4 million bp around the Duchenne muscular dystrophy gene on the human X-chromosome. Cell (1986) 2.12

The prevention of infection in appendicectomy wounds. Br J Surg (1971) 2.11

A 10-megabase physical map of human Xp21, including the Duchenne muscular dystrophy gene. Genomics (1988) 2.04

Heart transplantation in congenic strains of mice. Transplant Proc (1973) 1.97

Kidney transplants in mice. An analysis of the immune status of mice bearing long-term, H-2 incompatible transplants. J Exp Med (1978) 1.95

Pulmonary nocardiosis. Therapy with minocycline and with erythromycin plus ampicillin. JAMA (1973) 1.94

Complete coverage of the Schizosaccharomyces pombe genome in yeast artificial chromosomes. Nat Genet (1992) 1.93

Reaction of human lymphocytes in culture to components of the medium. Nature (1965) 1.92

Possible active enhancement of a human cadaver renal allograft with antilymphocyte serum (ALS) and donor bone marrow: case report of an initial attempt. Surgery (1976) 1.84

Controlled clinical trial of prophylactic human-leukocyte interferon in renal transplantation. Effects on cytomegalovirus and herpes simplex virus infections. N Engl J Med (1979) 1.83

Spoiling of transverse magnetization in steady-state sequences. Magn Reson Med (1991) 1.83

Antiserum to lymphocytes: prolonged survival of canine renal allografts. Science (1966) 1.81

Familial infantile convulsions and paroxysmal choreoathetosis: a new neurological syndrome linked to the pericentromeric region of human chromosome 16. Am J Hum Genet (1997) 1.79

NF-kappa B regulates IL-1 beta transcription through a consensus NF-kappa B binding site and a nonconsensus CRE-like site. J Immunol (1994) 1.78

Glomerulopathy associated with cytomegalovirus viremia in renal allografts. N Engl J Med (1981) 1.77

Two hundred one consecutive living-donor nephrectomies. Arch Surg (1998) 1.75

Humoral antibodies in renal allotransplantation in man. N Engl J Med (1970) 1.74

Analysis of IMGSAC autism susceptibility loci: evidence for sex limited and parent of origin specific effects. J Med Genet (2005) 1.74

A closer look at water-related geologic activity on Mars. Science (2007) 1.71

A conserved sorting-associated protein is mutant in chorea-acanthocytosis. Nat Genet (2001) 1.69

Elimination of transverse coherences in FLASH MRI. Magn Reson Med (1988) 1.67

Investigation of dyslexia and SLI risk variants in reading- and language-impaired subjects. Behav Genet (2010) 1.67

Conservation of the Duchenne muscular dystrophy gene in mice and humans. Science (1987) 1.66

Analysis of the human VPS13 gene family. Genomics (2004) 1.65

A missense mutation in connexin26, D66H, causes mutilating keratoderma with sensorineural deafness (Vohwinkel's syndrome) in three unrelated families. Hum Mol Genet (1999) 1.65

Isolation of the gene for McLeod syndrome that encodes a novel membrane transport protein. Cell (1994) 1.65

Functional MRI of pain- and attention-related activations in the human cingulate cortex. J Neurophysiol (1997) 1.65

FOXP2 is not a major susceptibility gene for autism or specific language impairment. Am J Hum Genet (2002) 1.63

Some effects of purified heterologous antihuman lymphocyte serum in man. Transplantation (1967) 1.62

Willingness to follow breast cancer. Survey of family physicians. Can Fam Physician (1996) 1.62

Effect of adult thymectomy on the recovery from immunological depression induced by anti-lymphocyte serum. Surg Forum (1965) 1.60

The SPCH1 region on human 7q31: genomic characterization of the critical interval and localization of translocations associated with speech and language disorder. Am J Hum Genet (2000) 1.60

Athabasca Valles, Mars: a lava-draped channel system. Science (2007) 1.58

Severity of disease and risk of malignant change in hereditary multiple exostoses. A genotype-phenotype study. J Bone Joint Surg Br (2004) 1.57

Mutational spectrum of the CHAC gene in patients with chorea-acanthocytosis. Eur J Hum Genet (2002) 1.56

Further evidence that the KIAA0319 gene confers susceptibility to developmental dyslexia. Mol Psychiatry (2006) 1.54

Studies in small bowel transplantation. Prevention of graft-versus-host disease with preservation of allograft function by donor pretreatment with antilymphocyte serum. Transplantation (1988) 1.52

Report of the committee on the genetic constitution of the X chromosome. Cytogenet Cell Genet (1990) 1.51

Immunologic and metabolic effects of caval versus portal venous drainage in small-bowel transplantation. Surgery (1988) 1.50

Procurement of a whole pancreas and liver from the same cadaveric donor. Surgery (1989) 1.49

An episode of ventricular tachycardia during long-duration spaceflight. Am J Cardiol (1998) 1.48

A molecular defect in loricrin, the major component of the cornified cell envelope, underlies Vohwinkel's syndrome. Nat Genet (1996) 1.47

Mutagenic and genotoxic effects of three vinyl chloride-induced DNA lesions: 1,N6-ethenoadenine, 3,N4-ethenocytosine, and 4-amino-5-(imidazol-2-yl)imidazole. Biochemistry (1993) 1.47

Screening of nine candidate genes for autism on chromosome 2q reveals rare nonsynonymous variants in the cAMP-GEFII gene. Mol Psychiatry (2003) 1.47

Genetic and phenotypic effects of phonological short-term memory and grammatical morphology in specific language impairment. Genes Brain Behav (2007) 1.46

High-density SNP association study and copy number variation analysis of the AUTS1 and AUTS5 loci implicate the IMMP2L-DOCK4 gene region in autism susceptibility. Mol Psychiatry (2009) 1.45

McLeod neuroacanthocytosis: genotype and phenotype. Ann Neurol (2001) 1.45

Controversies in organ donation: the altruistic living donor. Nephrol Dial Transplant (2001) 1.45

Who provides follow-up care for patients with early breast cancer? Can Fam Physician (1995) 1.41

Infectious disease syndromes attributable to cytomegalovirus and their significance among renal transplant recipients. Transplantation (1977) 1.40

All-silica single-mode optical fiber with photonic crystal cladding. Opt Lett (1996) 1.39

Medical research unit in a District General Hospital. Br Med J (1972) 1.39

Preemptive plasmapheresis and recurrence of FSGS in high-risk renal transplant recipients. Am J Transplant (2005) 1.38

Post transplantation donor-specific bone marrow transfusion in polyclonal antilymphocyte serum-treated recipients: the optimal cellular antigen for induction of unresponsiveness to organ allografts. Transplant Proc (1988) 1.38